BARTOLI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 23.430
AS - Asia 11.895
EU - Europa 11.040
SA - Sud America 1.783
Continente sconosciuto - Info sul continente non disponibili 1.245
AF - Africa 321
OC - Oceania 61
Totale 49.775
Nazione #
US - Stati Uniti d'America 22.093
IT - Italia 4.203
SG - Singapore 3.643
CN - Cina 2.301
VN - Vietnam 2.140
HK - Hong Kong 1.432
DE - Germania 1.374
BR - Brasile 1.271
RU - Federazione Russa 1.192
CA - Canada 1.024
SE - Svezia 715
IE - Irlanda 666
GB - Regno Unito 611
FR - Francia 584
BD - Bangladesh 467
IN - India 464
UA - Ucraina 323
FI - Finlandia 275
ID - Indonesia 213
NL - Olanda 200
TR - Turchia 197
ES - Italia 195
KR - Corea 169
AR - Argentina 162
MX - Messico 144
PL - Polonia 140
IQ - Iraq 133
AT - Austria 123
ZA - Sudafrica 102
JP - Giappone 101
CH - Svizzera 93
PK - Pakistan 93
EC - Ecuador 82
CO - Colombia 77
PH - Filippine 71
SA - Arabia Saudita 71
AE - Emirati Arabi Uniti 56
DK - Danimarca 56
BE - Belgio 53
AU - Australia 52
VE - Venezuela 49
MY - Malesia 45
UZ - Uzbekistan 45
KE - Kenya 44
EG - Egitto 40
CL - Cile 36
CZ - Repubblica Ceca 34
JM - Giamaica 34
IR - Iran 33
MA - Marocco 32
TN - Tunisia 32
UY - Uruguay 32
PT - Portogallo 29
PY - Paraguay 26
CR - Costa Rica 25
HU - Ungheria 24
PE - Perù 24
JO - Giordania 23
IL - Israele 22
NP - Nepal 21
NO - Norvegia 18
HN - Honduras 17
NI - Nicaragua 17
TW - Taiwan 17
BO - Bolivia 16
LT - Lituania 16
OM - Oman 15
AZ - Azerbaigian 14
ET - Etiopia 14
KZ - Kazakistan 14
AL - Albania 13
DO - Repubblica Dominicana 13
BG - Bulgaria 12
EE - Estonia 12
LB - Libano 12
MD - Moldavia 12
KG - Kirghizistan 10
LV - Lettonia 10
PS - Palestinian Territory 10
SN - Senegal 10
NZ - Nuova Zelanda 9
PR - Porto Rico 9
SV - El Salvador 9
TT - Trinidad e Tobago 9
DZ - Algeria 8
GY - Guiana 8
LU - Lussemburgo 8
SY - Repubblica araba siriana 8
TH - Thailandia 8
AO - Angola 7
BH - Bahrain 7
BY - Bielorussia 7
EU - Europa 7
GR - Grecia 7
GT - Guatemala 6
PA - Panama 6
RO - Romania 6
BA - Bosnia-Erzegovina 5
DM - Dominica 5
LY - Libia 5
Totale 48.427
Città #
Ashburn 2.406
Ann Arbor 2.245
Singapore 2.147
San Jose 1.559
Hong Kong 1.383
Milan 1.183
Fairfield 949
Woodbridge 897
Chandler 777
Houston 759
Frankfurt am Main 733
Toronto 690
Ho Chi Minh City 624
New York 605
Dublin 578
Wilmington 550
Hanoi 529
Dallas 511
Santa Clara 489
Council Bluffs 488
Los Angeles 445
Seattle 425
Chicago 345
Jacksonville 322
Cambridge 319
Beijing 318
Dearborn 311
Hefei 276
The Dalles 273
Princeton 246
Rome 245
Munich 202
Menlo Park 188
Lauterbourg 151
Jakarta 142
Buffalo 137
Nanjing 132
Boardman 131
Seoul 131
Shanghai 130
Columbus 127
Helsinki 127
Moscow 124
São Paulo 122
Lawrence 114
Phoenix 109
Altamura 104
Orem 103
Vienna 97
Denver 94
Da Nang 93
Montreal 86
Atlanta 83
Tokyo 76
Haiphong 74
Naples 73
Nuremberg 73
Brooklyn 71
Guangzhou 71
Warsaw 70
San Diego 67
Zurich 64
Turin 61
Washington 60
London 59
San Francisco 59
Figino 56
Baghdad 55
Chennai 53
Lachine 50
Romola 50
Boston 49
Delhi 49
Istanbul 46
Kent 45
Nanchang 45
Sesto San Giovanni 45
Stockholm 44
Tianjin 43
Brussels 42
Johannesburg 42
Salt Lake City 42
Tashkent 41
Florence 40
Genoa 40
Rio de Janeiro 40
Biên Hòa 39
Lappeenranta 39
Lissone 39
Changsha 38
Philadelphia 38
Poplar 38
Turku 37
Nairobi 36
Zhengzhou 36
Andover 35
Hải Dương 33
Jinan 33
Miami 33
Valencia 33
Totale 28.656
Nome #
Disturbi mentali gravi e sindrome metabolica: meta-analisi e studio trasversale comparativo 943
Anxious distress in people with major depressive episodes: a cross-sectional analysis of clinical correlates 669
Clinical correlates of comorbid attention deficit hyperactivity disorder in adults suffering from bipolar disorder: A meta-analysis 654
Mental health and loneliness in university students: A structural equation modelling comparing Italy and the UK 636
Surveilling COVID-19 emotional contagion on Twitter 609
The Kynurenine Pathway in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis of Blood Concentrations of Tryptophan and Its Catabolites 586
The role of BDNF in major depressive disorder, related clinical features, and antidepressant treatment: Insight from meta-analyses 540
Leveraging Prompt Engineering and Large Language Models for Automating MADRS Score Computation for Depression Severity Assessment 466
Facial emotion recognition in people with schizophrenia and a history of violence: a mediation analysis 440
Evidence from preclinical and clinical metabolomics studies on the antidepressant effects of ketamine and esketamine 432
Acute cognitive and psychiatric effects of cannabinoids 423
The mediating role of depression in pathways linking positive and negative symptoms in schizophrenia. A longitudinal analysis using latent variable structural equation modelling 414
Digital health interventions for mental health disorders: an umbrella review of meta-analyses of randomised controlled trials 412
Executive control in schizophrenia: a preliminary study on the moderating role of COMT Val158Met for comorbid alcohol and substance use disorders 405
Impact of a Mobile E-Health Intervention on Binge Drinking in Young People: The Digital-Alcohol Risk Alertness Notifying Network for Adolescents and Young Adults Project 399
Acoustic and Natural Language Markers for Bipolar Disorder: A Pilot, mHealth Cross-Sectional Study 395
La comorbilità psichiatrica nei soggetti con disturbi correlati all'uso di cannabis 394
Adjunctive second-generation antipsychotics for specific symptom domains of schizophrenia resistant to clozapine: A meta-analysis 391
The Resistant Depression Response to Esketamine Assessing Metabolomics (ReDREAM) Project- Untargeted Metabolomics to Identify Biomarkers of Treatment Response to Intranasal Esketamine in Individuals with Treatment-Resistant Depression: A Study Protocol 390
Disentangling the association between child abuse and eating disorders: A systematic review and meta-analysis 386
Testing the association of serum uric acid levels with behavioral and clinical characteristics in subjects with major affective disorders: A cross-sectional study 381
Prevalence and Correlates of Binge Drinking among Young Adults Using Alcohol: A Cross-Sectional Survey 374
E-health app to reduce binge drinking among adolescents and young adults: the D-ARIANNA Project 368
Exploring depression in people with schizophrenia spectrum disorders: A cross-sectional analysis of the clinical relationship with Positive and Negative Syndrome Scale dimensions 366
Schizoaffective disorder and metabolic syndrome: A meta-analytic comparison with schizophrenia and other non-affective psychoses 361
Ketamine as a rapid-acting agent for suicidal ideation: A meta-analysis 350
Tolerability of vortioxetine compared to selective serotonin reuptake inhibitors in older adults with major depressive disorder (VESPA): a randomised, assessor-blinded and statistician-blinded, multicentre, superiority trial 349
Antipsychotic dose mediates the association between polypharmacy and corrected QT interval 348
Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy 338
Bipolar disorder, schizophrenia, and metabolic syndrome 337
Facial emotion recognition in alcohol and substance use disorders: A meta-analysis 337
Clinical and metabolic correlates of DSM-5 mixed features in subjects with bipolar depression and mania: A cross-sectional study 336
Combining predominant polarity and affective spectrum concepts in bipolar disorder: towards a novel theoretical and clinical perspective 336
Cardiovascular risk factors among people with severe mental illness in Italy: A cross sectional comparative study 336
Defense Mechanisms, Personality Disorders and Eating Disorders: a comparison 336
Psychotic Disorders and Substance Use Disorders 333
Comparing Long-Acting Antipsychotic Discontinuation Rates Under Ordinary Clinical Circumstances: A Survival Analysis from an Observational, Pragmatic Study 333
Blood concentrations of neopterin and biopterin in subjects with depression: A systematic review and meta-analysis 332
Area-Level Deprivation and Adverse Consequences in People With Substance Use Disorders: Findings From the Psychiatric and Addictive Dual Disorder in Italy (PADDI) Study 326
Validity and clinical utility of the DSM-5 severity specifier for bulimia nervosa: results from a multisite sample of patients who received evidence-based treatment 325
Posttraumatic stress disorder and risk of obesity: Systematic review and meta-analysis 324
Comorbid Anxiety and Alcohol or Substance Use Disorders: An Overview 323
Risk Estimation Modeling and Feasibility Testing for a Mobile eHealth Intervention for Binge Drinking among Young People: The D-ARIANNA (Digital-Alcohol RIsk Alertness Notifying Network for Adolescents and young adults) Project 323
Therapy and rehabilitation in gambling disorder: Possibilities and limits 321
Facial emotion recognition in schizophrenia: An exploratory study on the role of comorbid alcohol and substance use disorders and COMT Val158Met 321
Association between depression and non-fatal overdoses among drug users: A systematic review and meta-analysis 318
Metabolic Syndrome in People Suffering from Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis 318
The multidimensional diagnostic assessment in gambling disorder 318
Testing the role of the antioxidant uric acid as a biomarker of suicidal ideation in subjects with major affective disorders: An exploratory study 318
Metabolic Syndrome Among People with PTSD: Epidemiological Overview 316
Effect of clinical response to active drugs and placebo on antipsychotics and mood stabilizers relative efficacy for bipolar depression and mania: A meta-regression analysis 316
The prevalence of metabolic syndrome in people with severe mental illness: a mediation analysis 312
Understanding University Students' Perspectives towards Digital Tools for Mental Health Support: A Cross-country Study 311
Antioxidant uric acid in treated and untreated subjects with major depressive disorder: A meta-analysis and meta-regression 311
Association between depression and neuropathy in people with type 2 diabetes: a meta-analysis 309
Risk and maintenance factors for young women’s DSM-5 eating disorders 308
Uric acid levels in subjects with bipolar disorder: A comparative meta-analysis 305
Depression after stroke and risk of mortality: A systematic review and meta-analysis 303
Poverty matters: Cannabis use among people with serious mental illness: Findings from the United States survey on drug use and health, 2015 303
Plasma adiponectin levels in schizophrenia and role of second-generation antipsychotics: A meta-analysis 302
Facial emotion recognition performance influences executive control impairment in Anorexia Nervosa: an exploratory study 299
Immune-inflammatory markers and psychosis risk: A systematic review and meta-analysis 299
Prevalence and correlates of QTc prolongation in Italian psychiatric care: Cross-sectional multicentre study 297
Web- and text-based interventions for smoking cessation: Meta-analysis and meta-regression 294
Engagement in the Overdose RIsk InfOrmatioN (ORION) e-Health Tool for Opioid Overdose Prevention and Self-Efficacy: A Preliminary Study 292
Exploring the predictive role of the first mood episode on the predominant polarity in bipolar disorder: insights from a path analysis 291
Comparing 1-year effectiveness and acceptability of once-monthly paliperidone palmitate and aripiprazole monohydrate for schizophrenia spectrum disorders: Findings from the STAR Network Depot Study 290
Update on bipolar disorder biomarker candidates: what about uric acid/adenosine hypothesis? 289
Purinergic system and suicidal behavior: exploring the link between adenosine A2A receptors and depressive/impulsive features 285
Untreated depression and non-medical use of prescription pain relievers: findings from the National Survey on Drug Use and Health 2008-2014 284
Attempted suicide in people with co-occurring bipolar and substance use disorders: Systematic review and meta-analysis 282
Detecting binge drinking and alcohol-related risky behaviours from twitter’s users: An exploratory content-and topology-based analysis 281
Clinical Utility of Long-Acting Injectable Risperidone in Schizophrenia and Bipolar I Disorder: A Review of Clinical Studies 279
First-generation antipsychotics and QTc: any role for mediating variables? 279
Ketamine for suicidal ideation treatment: Available evidence remains convincing 279
Blood concentrations of anterior pituitary hormones in drug-naïve people with first-episode psychosis: A systematic review and meta-analysis 278
Lipid profile and suicide attempt in bipolar disorder: A meta-analysis of published and unpublished data 278
Comorbid addiction and major mental illness in Europe: A narrative review 276
The association between post-stroke depression and mortality: a metaanalysis 276
Professionals’ Digital Training for Child Maltreatment Prevention in the COVID-19 Era: A Pan-European Model 276
Disentangling the Association between ADHD and Alcohol Use Disorder in Individuals Suffering from Bipolar Disorder: A Systematic Review and Meta-Analysis 275
Digital mental health interventions for anxiety and depressive symptoms in university students during the COVID-19 pandemic: A systematic review of randomized controlled trials [Intervenciones digitales de salud mental para los síntomas ansiosos y depresivos en estudiantes universitarios durante la pandemia de COVID-19: una revisión sistemática de pruebas controladas aleatorizadas] 273
Cannabidiol for Mood Disorders: A Call for More Research 269
Differences in serum uric acid between ‘unipolar’ and ‘bipolar’ depression: Preliminary data 268
Testing the Impact of Depressive and Anxiety Features on the Association between Attention-Deficit/Hyperactivity Disorder Symptoms and Academic Performance among University Students: A Mediation Analysis 267
Effect of long-acting injectable antipsychotics on emergency department visits and hospital admissions in people with bipolar disorder: A retrospective mirror-image analysis from the Northern Milan Area Cohort (NOMIAC) study 267
Ketamine and esketamine for suicidal ideation: Recent progress and practical issues 264
Purinergic dysfunction in bipolar disorder: any role for the antioxidant uric acid as a trait and state biomarker? 263
Metabolic dysfunctions in people with post-traumatic stress disorder 262
Mental Health and COVID-19 in University Students: Findings from a Qualitative, Comparative Study in Italy and the UK 261
Recent suicide attempts and serum lipid profile in subjects with mental disorders: A cross-sectional study 261
Complete blood count-based inflammation indexes and symptom severity in people with schizophrenia spectrum disorders: An analysis based on structural equation modelling 260
Cannabis use disorder as a correlate of suicide attempts among people with bipolar disorder 259
Association of depression and SSRIs with mortality after stroke 258
Prevalence and correlates of manic/hypomanic and depressive predominant polarity in bipolar disorder: Systematic review and meta-analysis 257
Cannabis use disorder and suicide attempts in bipolar disorder: A meta-analysis 257
Pre-discharge predictors of 1-year rehospitalization in adolescents and young adults with severe mental disorders: A retrospective cohort study 257
Influence of prior contact with community mental health services on first inpatient psychiatric admission for ethnic minorities: Findings from the NOMIAC study 255
Benefits and harms of low and high second-generation antipsychotics doses for bipolar depression: A meta-analysis 254
The kynurenine pathway in bipolar disorder: a meta-analysis on the peripheral blood levels of tryptophan and related metabolites 252
Totale 34.109
Categoria #
all - tutte 156.184
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 156.184


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.326 0 0 0 145 132 146 90 106 140 144 161 262
2022/20233.372 373 983 241 295 204 485 86 227 204 60 130 84
2023/20242.557 76 102 119 204 342 573 371 168 210 55 63 274
2024/20257.458 480 634 475 390 481 454 507 296 728 1.096 713 1.204
2025/202618.834 2.364 1.342 1.369 1.770 1.997 1.015 2.538 902 1.271 1.534 1.379 1.353
2026/20275.773 985 1.355 2.038 1.395 0 0 0 0 0 0 0 0
Totale 49.775